Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms
×
ofatumumab
×
Clear all
Filters
3
NCT01077518
2020-03-27
A+B
Novartis
Phase 3
Terminated
346 enrolled
41 charts
NCT00748189
2019-06-25
COMPLEMENT 1
Novartis
Phase 3
Terminated
447 enrolled
32 charts
NCT01014208
2015-08-07
ORCHARRD
GlaxoSmithKline
Phase 3
Completed
447 enrolled
21 charts